| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant therapy for HER2+ breast cancer: practice, perception, and toxicity
|
Rocque, Gabrielle
|
|
2011
|
131 |
2 |
p. 713-721
|
artikel
|
| 2 |
Are genetic and environmental components of variance in mammographic density measures that predict breast cancer risk independent of within-twin pair differences in body mass index?
|
Dite, Gillian S.
|
|
2011
|
131 |
2 |
p. 553-559
|
artikel
|
| 3 |
Aspirin use and breast cancer risk: a meta-analysis
|
Luo, Ting
|
|
2011
|
131 |
2 |
p. 581-587
|
artikel
|
| 4 |
Body mass index and risk of second primary breast cancer: The WECARE Study
|
Brooks, Jennifer D.
|
|
2011
|
131 |
2 |
p. 571-580
|
artikel
|
| 5 |
Bone marrow versus sentinel lymph node involvement in breast cancer: a comparison of early hematogenous and early lymphatic tumor spread
|
Hartkopf, Andreas D.
|
|
2011
|
131 |
2 |
p. 501-508
|
artikel
|
| 6 |
BRCA1 c.4987-3C>G is a pathogenic mutation
|
Brandão, Rita D.
|
|
2011
|
131 |
2 |
p. 723-725
|
artikel
|
| 7 |
Change in physical activity during active treatment in a prospective study of breast cancer survivors
|
Kwan, Marilyn L.
|
|
2011
|
131 |
2 |
p. 679-690
|
artikel
|
| 8 |
Changes in perceived attentional function in women following breast cancer surgery
|
Chen, Mei-Ling
|
|
2011
|
131 |
2 |
p. 599-606
|
artikel
|
| 9 |
Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial
|
Pritchard, Kathleen I.
|
|
2011
|
131 |
2 |
p. 541-551
|
artikel
|
| 10 |
Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes
|
Kim, Jiyoung
|
|
2011
|
131 |
2 |
p. 527-540
|
artikel
|
| 11 |
Compliance and persistence of endocrine adjuvant breast cancer therapy
|
Güth, Uwe
|
|
2011
|
131 |
2 |
p. 491-499
|
artikel
|
| 12 |
Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American women
|
Stark, Azadeh
|
|
2011
|
131 |
2 |
p. 561-570
|
artikel
|
| 13 |
Dual HER2-targeted approaches in HER2-positive breast cancer
|
Ahn, Eugene R.
|
|
2011
|
131 |
2 |
p. 371-383
|
artikel
|
| 14 |
Effect of simvastatin on the pharmacokinetics of anastrozole
|
Bao, Ting
|
|
2011
|
131 |
2 |
p. 709-711
|
artikel
|
| 15 |
Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b
|
Sandhu, Rupninder
|
|
2011
|
131 |
2 |
p. 385-399
|
artikel
|
| 16 |
Erratum to: Evaluation of variants in the CHEK2, BRIP1 and PALB2 genes in an Irish breast cancer cohort
|
McInerney, N. M.
|
|
2011
|
131 |
2 |
p. 729
|
artikel
|
| 17 |
Erratum to: The TGFBR1*6A/9A polymorphism is not associated with differential risk of breast cancer
|
Colleran, Gabrielle
|
|
2011
|
131 |
2 |
p. 727
|
artikel
|
| 18 |
Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance
|
Retèl, Valesca P.
|
|
2011
|
131 |
2 |
p. 627-636
|
artikel
|
| 19 |
Influence of stromal–epithelial interactions on breast cancer in vitro and in vivo
|
Potter, Shirley M.
|
|
2011
|
131 |
2 |
p. 401-411
|
artikel
|
| 20 |
Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis
|
Wang, Yuting
|
|
2011
|
131 |
2 |
p. 357-369
|
artikel
|
| 21 |
Lack of any association between functionally significant CYP2D6 polymorphisms and clinical outcomes in early breast cancer patients receiving adjuvant tamoxifen treatment
|
Park, In Hae
|
|
2011
|
131 |
2 |
p. 455-461
|
artikel
|
| 22 |
Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy—Breast (FACT-B) in Asian breast cancer patients
|
Ng, Raymond
|
|
2011
|
131 |
2 |
p. 619-625
|
artikel
|
| 23 |
Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project
|
Beasley, Jeannette M.
|
|
2011
|
131 |
2 |
p. 637-643
|
artikel
|
| 24 |
miRNA-34a is associated with docetaxel resistance in human breast cancer cells
|
Kastl, L.
|
|
2011
|
131 |
2 |
p. 445-454
|
artikel
|
| 25 |
Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients
|
Chaher, Nabila
|
|
2011
|
131 |
2 |
p. 437-444
|
artikel
|
| 26 |
Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy
|
Hein, R.
|
|
2011
|
131 |
2 |
p. 653-661
|
artikel
|
| 27 |
Predictive value of neoadjuvant chemotherapy failure in breast cancer using FDG–PET after the first course
|
Kolesnikov-Gauthier, Hélène
|
|
2011
|
131 |
2 |
p. 517-525
|
artikel
|
| 28 |
Prognostic impact of isolated tumor cells in breast cancer axillary nodes: single tumor cell(s) versus tumor cell cluster(s) and microanatomic location
|
Vestjens, Johanna H.
|
|
2011
|
131 |
2 |
p. 645-651
|
artikel
|
| 29 |
Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer
|
Han, Yunwei
|
|
2011
|
131 |
2 |
p. 483-490
|
artikel
|
| 30 |
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer
|
Livaudais, Jennifer C.
|
|
2011
|
131 |
2 |
p. 607-617
|
artikel
|
| 31 |
Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients
|
Ligibel, Jennifer A.
|
|
2011
|
131 |
2 |
p. 589-597
|
artikel
|
| 32 |
Routine pathologic parameters can predict Oncotype DXTM recurrence scores in subsets of ER positive patients: who does not always need testing?
|
Allison, K. H.
|
|
2011
|
131 |
2 |
p. 413-424
|
artikel
|
| 33 |
Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA)
|
Godey, Florence
|
|
2011
|
131 |
2 |
p. 509-516
|
artikel
|
| 34 |
Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer
|
Lu, Wenjie Jessie
|
|
2011
|
131 |
2 |
p. 473-481
|
artikel
|
| 35 |
The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms
|
Shanmugam, Victoria K.
|
|
2011
|
131 |
2 |
p. 699-708
|
artikel
|
| 36 |
The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models
|
Zhao, Hong
|
|
2011
|
131 |
2 |
p. 425-436
|
artikel
|
| 37 |
The p160 ER co-regulators predict outcome in ER negative breast cancer
|
Spears, Melanie
|
|
2011
|
131 |
2 |
p. 463-472
|
artikel
|
| 38 |
The relationship between twin births and maternal risk of breast cancer: a meta-analysis
|
Kim, Hye Sook
|
|
2011
|
131 |
2 |
p. 671-677
|
artikel
|
| 39 |
Use of high technology imaging for surveillance of early stage breast cancer
|
Panageas, K. S.
|
|
2011
|
131 |
2 |
p. 663-670
|
artikel
|
| 40 |
Variation between hospitals in surgical margins after first breast-conserving surgery in the Netherlands
|
Heiden-van der Loo, Margriet van der
|
|
2011
|
131 |
2 |
p. 691-698
|
artikel
|
Tijdschrift beschrijving